These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported Terminated||2006-002851-33||Sorafenib and Bevacizumab as first- line treatment in patients with advanced renal cell carcinoma||2009-03-01||due-trials|